SUBGAM Trademark

Trademark Overview

On Tuesday, February 28, 2017, a trademark application was filed for SUBGAM with the United States Patent and Trademark Office. The USPTO has given the SUBGAM trademark a serial number of 87352475. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 6, 2020. This trademark is owned by Bio Products Laboratory Limited. The SUBGAM trademark is filed in the Pharmaceutical Products category with the following description:

Subcutaneous immune globulin for treatment of immune deficiency and autoimmune disorders, diseases, and conditions
subgam

General Information

Serial Number87352475
Word MarkSUBGAM
Filing DateTuesday, February 28, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesSubcutaneous immune globulin for treatment of immune deficiency and autoimmune disorders, diseases, and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBio Products Laboratory Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHertfordshire WD63BX
GB
Party NameBio Products Laboratory Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHertfordshire, WD6 3BX
GB

Trademark Events

Event DateEvent Description
Monday, July 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 28, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 27, 2019EXTENSION 4 GRANTED
Monday, November 25, 2019EXTENSION 4 FILED
Monday, November 25, 2019TEAS EXTENSION RECEIVED
Saturday, June 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 31, 2019EXTENSION 3 GRANTED
Wednesday, May 29, 2019EXTENSION 3 FILED
Wednesday, May 29, 2019TEAS EXTENSION RECEIVED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 13, 2018EXTENSION 2 GRANTED
Wednesday, December 5, 2018EXTENSION 2 FILED
Thursday, December 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 5, 2018TEAS EXTENSION RECEIVED
Tuesday, April 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 13, 2018EXTENSION 1 GRANTED
Friday, April 13, 2018EXTENSION 1 FILED
Friday, April 13, 2018TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 31, 2017ASSIGNED TO LIE
Thursday, August 17, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2017NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2017ASSIGNED TO EXAMINER
Tuesday, March 7, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 3, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

subgam immune disorders diseases conditions autoimmune deficiency globulin treatment subcutaneous